Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PODD Insulet Corp
- Stocks
- Healthcare
- NASDAQ: PODD
Price (delayed)
$301.62
Market cap
$21.23B
P/E Ratio
52.55
Dividend/share
N/A
EPS
$5.74
Enterprise value
$21.64B
Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod
Highlights
The equity has soared by 68% YoY and by 10% QoQ
Insulet's quick ratio has increased by 31% YoY and by 30% from the previous quarter
PODD's price to earnings (P/E) is 98% lower than its 5-year quarterly average of 2608.3 but 28% higher than its last 4 quarters average of 41.0
PODD's net income has surged by 72% year-on-year but it is down by 3.8% since the previous quarter
The company's debt rose by 23% QoQ and by 21% YoY
Key stats
What are the main financial stats of PODD
Market
Valuations
Earnings
Shares outstanding
70.37M
Market cap
$21.23B
Enterprise value
$21.64B
Price to earnings (P/E)
52.55
Price to book (P/B)
15.92
Price to sales (P/S)
9.64
EV/EBIT
64.67
EV/EBITDA
51.73
EV/Sales
9.84
Revenue
$2.2B
Gross profit
$1.55B
Operating income
$340.8M
Net income
$402.2M
EBIT
$334.6M
EBITDA
$418.3M
Free cash flow
$280.8M
Per share
Balance sheet
Liquidity
EPS
$5.74
EPS diluted
$5.55
Free cash flow per share
$4
Book value per share
$18.95
Revenue per share
$31.29
TBVPS
$47.9
Total assets
$3.52B
Total liabilities
$2.19B
Debt
$1.7B
Equity
$1.33B
Working capital
$1.81B
Debt to equity
1.27
Current ratio
4.47
Quick ratio
3.24
Net debt/EBITDA
0.99
Margins
Efficiency
Dividend
EBITDA margin
19%
Gross margin
70.4%
Net margin
18.3%
Operating margin
15.5%
Return on assets
12.9%
Return on equity
34.5%
Return on invested capital
11.4%
Return on capital employed
11.2%
Return on sales
15.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PODD stock price
How has the Insulet stock price performed over time
Intraday
0.54%
1 week
-1.51%
1 month
-7.19%
1 year
52.96%
YTD
15.53%
QTD
-4%
Financial performance
How have Insulet's revenue and profit performed over time
Revenue
$2.2B
Gross profit
$1.55B
Operating income
$340.8M
Net income
$402.2M
Gross margin
70.4%
Net margin
18.3%
PODD's net income has surged by 72% year-on-year but it is down by 3.8% since the previous quarter
The company's net margin rose by 40% YoY but it fell by 9% QoQ
Insulet's operating income has increased by 37% YoY and by 10% QoQ
PODD's gross profit is up by 26% YoY and by 7% from the previous quarter
Price vs fundamentals
How does PODD's price correlate with its fundamentals
Growth
What is Insulet's growth rate over time
Valuation
What is Insulet stock price valuation
P/E
52.55
P/B
15.92
P/S
9.64
EV/EBIT
64.67
EV/EBITDA
51.73
EV/Sales
9.84
PODD's price to earnings (P/E) is 98% lower than its 5-year quarterly average of 2608.3 but 28% higher than its last 4 quarters average of 41.0
The EPS has soared by 71% YoY but it has contracted by 3.9% from the previous quarter
The equity has soared by 68% YoY and by 10% QoQ
PODD's price to book (P/B) is 45% less than its 5-year quarterly average of 28.7 but 11% more than its last 4 quarters average of 14.4
PODD's price to sales (P/S) is 27% lower than its 5-year quarterly average of 13.2 but 16% higher than its last 4 quarters average of 8.3
PODD's revenue is up by 23% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is Insulet business performance
The return on assets has increased by 39% year-on-year but it has declined by 10% since the previous quarter
PODD's ROE is down by 15% QoQ
The ROS has contracted by 8% from the previous quarter and by 4.4% YoY
Insulet's return on invested capital has decreased by 7% QoQ but it has increased by 7% YoY
Dividends
What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PODD.
Financial health
How did Insulet financials performed over time
The total assets is 61% higher than the total liabilities
The total assets rose by 34% YoY and by 14% QoQ
Insulet's quick ratio has increased by 31% YoY and by 30% from the previous quarter
The company's debt is 27% higher than its equity
The equity has soared by 68% YoY and by 10% QoQ
The debt to equity has decreased by 28% YoY but it has increased by 11% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.